Literature DB >> 19846923

c-FLIP gene silencing eliminates tumor cells in breast cancer xenografts without affecting stromal cells.

Travis W Day1, Anthony L Sinn, Su Huang, Karen E Pollok, George E Sandusky, Ahmad R Safa.   

Abstract

Cellular FLICE-like inhibitory protein (c-FLIP) is an inhibitor of death receptor-mediated apoptosis and exerts its anti-apoptotic function by blocking the activation of caspase-8. We recently showed that the siRNA-mediated knockdown of c-FLIP in MCF-7 breast cancer cells growing in vitro triggered apoptosis. The aim of this study was to determine if the in vivo knockdown of c-FLIP in MCF-7 breast cancer xenografts affected tumor viability. Immunohistochemical detection of c-FLIP in the tumor sections revealed that the knockdown of c-FLIP eliminated the neoplastic cells within the breast cancer xenografts without affecting the normal stromal and fibroblastic cells. These results indicate that c-FLIP is required for breast cancer growth and is a relevant therapeutic target for the treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19846923

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  10 in total

1.  4-(4-Chloro-2-methylphenoxy)-N-hydroxybutanamide (CMH) targets mRNA of the c-FLIP variants and induces apoptosis in MCF-7 human breast cancer cells.

Authors:  Khadijeh Bijangi-Vishehsaraei; Mohammad Reza Saadatzadeh; Su Huang; Ahmad R Safa; Michael P Murphy
Journal:  Mol Cell Biochem       Date:  2010-05-06       Impact factor: 3.396

2.  Cellular FLIP long isoform (cFLIPL)-IKKα interactions inhibit IRF7 activation, representing a new cellular strategy to inhibit IFNα expression.

Authors:  Lauren T Gates-Tanzer; Joanna L Shisler
Journal:  J Biol Chem       Date:  2017-12-08       Impact factor: 5.157

3.  Suppression of apoptosis inhibitor c-FLIP selectively eliminates breast cancer stem cell activity in response to the anti-cancer agent, TRAIL.

Authors:  Luke Piggott; Nader Omidvar; Salvador Martí Pérez; Rhiannon French; Matthias Eberl; Richard W E Clarkson
Journal:  Breast Cancer Res       Date:  2011-09-14       Impact factor: 6.466

4.  Targeting the Anti-Apoptotic Protein c-FLIP for Cancer Therapy.

Authors:  Ahmad R Safa; Karen E Pollok
Journal:  Cancers (Basel)       Date:  2011-06       Impact factor: 6.639

5.  Expression levels of heat shock protein 27 and cellular FLICE-like inhibitory protein in prostate cancer correlate with Gleason score sum and pathologic stage.

Authors:  Seung Wook Lee; Jeoung Man Cho; Hee Ju Cho; Jung Yoon Kang; Eun Kyung Kim; Tag Keun Yoo
Journal:  Korean J Urol       Date:  2015-07-07

6.  Dual silencing of Hsp27 and c-FLIP enhances doxazosin-induced apoptosis in PC-3 prostate cancer cells.

Authors:  Sang Soo Kim; Hee-Ju Cho; Jeong-Man Cho; Jung Yoon Kang; Hyun-Won Yang; Tag Keun Yoo
Journal:  ScientificWorldJournal       Date:  2013-06-19

Review 7.  Restoring TRAILR2/DR5-Mediated Activation of Apoptosis upon Endoplasmic Reticulum Stress as a Therapeutic Strategy in Cancer.

Authors:  Rocío Mora-Molina; Abelardo López-Rivas
Journal:  Int J Mol Sci       Date:  2022-08-12       Impact factor: 6.208

8.  Oncogenic p95HER2/611CTF primes human breast epithelial cells for metabolic stress-induced down-regulation of FLIP and activation of TRAIL-R/Caspase-8-dependent apoptosis.

Authors:  Rosa Martín-Pérez; Rosario Yerbes; Rocío Mora-Molina; Ana Cano-González; Joaquín Arribas; Massimiliano Mazzone; Abelardo López-Rivas; Carmen Palacios
Journal:  Oncotarget       Date:  2017-10-03

9.  Involvement of both caspase-8 and Noxa-activated pathways in endoplasmic reticulum stress-induced apoptosis in triple-negative breast tumor cells.

Authors:  Ana Cano-González; Marta Mauro-Lizcano; Daniel Iglesias-Serret; Joan Gil; Abelardo López-Rivas
Journal:  Cell Death Dis       Date:  2018-01-26       Impact factor: 8.469

10.  cFLIP downregulation is an early event required for endoplasmic reticulum stress-induced apoptosis in tumor cells.

Authors:  Rocío Mora-Molina; Daniela Stöhr; Markus Rehm; Abelardo López-Rivas
Journal:  Cell Death Dis       Date:  2022-02-03       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.